application
Endoluminal Strictures
Of all biliary strictures are malignant, most caused by cholangiocarcinoma or pancreatic cancer.1
Of patients will experience stent occlusion within 6–8 months, leading to repeat interventions2
Liver transplant patients may develop benign biliary strictures, underscoring the need for adjunct therapies like biliary RFA.3
ELRA™ is a temperature-controlled RF catheter designed for endoluminal ablation of biliary and pancreatic ducts. By ablating tumor or fibrotic tissue intraductally, ELRA™ helps restore duct patency and improve stent outcomes.
ELRA™ is introduced over-the-wire (OTW) into the hepatopancreatobiliary ducts under fluoroscopic guidance.
Controlled radiofrequency energy ablates tumor or fibrotic tissue intraductally.
Restored lumen patency, optimized stent placement, and reduced need for repeat interventions.
11, 18, 22, 33 mm for a tailored endoluminal ablation
To provide real-time impedance and temperature monitoring
With a conical silicone tip for easy navigation through narrow ducts
ELRA™ gives physicians the flexibility to tailor ablation to duct size, stricture length, and patient anatomy.
*Recommended size for anatomy.
Prospective single- and multicenter studies have shown temperature-controlled intraductal RFA using ELRA™ to be feasible, safe, and effective in maintaining biliary patency5,6 . Temperature control prevents excessive heating, minimizing the risk of vascular or ductal injury.
Obstructed duct with fibrotic tissue
Restored lumen, improved bile flow
Discover how ELRA™ enables precise, safe, and effective ablation for malignant and benign biliary strictures.
See how safe and effective STARmed’s industry-leading equipment is in practice.
By submitting this form, you consent to receive marketing emails from STARmed America at the email provided. You can unsubscribe at any time. Please see our privacy policy for more information.
